Reason for termination from study | *1FUV ¶M1 | 2FUV M2 | 3FUV M3 | 4FUV M6 | 5FUV M9 | 6FUV M12 | 7FUV M15 | 8FUV M18 | 9FUV M21 | 10FUV M24 | N (%) |
Death of HESN study participant | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 5 (4.4) |
Migrated from study area | 3 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 6 (5.2) |
HESN seroconverted | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 3 (2.6) |
Unable to reach or locate (attrition) | 1 | 0 | 2 | 2 | 5 | 5 | 9 | 2 | 0 | 0 | 26 (22.6) |
Separate/Divorce from HIV+ partner (thus ineligible to remain in study) | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 2 | 4 | 0 | 17 (14.8) |
Death of HIV+ partner (thus ineligible to remain in the study) | 0 | 3 | 3 | 5 | 3 | 3 | 3 | 3 | 0 | 0 | 23 (20) |
Unwilling to continue study | 15 | 1 | 1 | 2 | 1 | 2 | 2 | 0 | 1 | 1 | 26 (22.6) |
Pregnancy (thus ineligible to remain in study) | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 6 (5.2) |
Participant withdrew consent | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 3 (2.6) |
Total N (%) | 22 (19) | 9 (8) | 9 (8) | 14 (12) | 14 (12) | 14 (12) | 16 (14) | 10 (9) | 5 (4.3) | 2 (1.7) | 115 (100) |